The global impetigo drug market is anticipated to grow at a significant CAGR of 7.1% during the forecast period. One of the major factors that are augmenting the growth of the impetigo drug market rising mode of transmission of impetigo diseases. Impetigo is a highly infectious skin condition that primarily affects toddlers and new born. The bacteria streptococcus or staphylococcus aureus produce this form of infection. This infection causes red sores or bumps blisters on the patient's face, especially around the nose, feet, hands, and mouth. This condition affects generally those who participate in sports that require close physical contacts, such as wrestling and rugby. Furthermore, topical treatments can assist to alleviate the disease's symptoms. As a result, producers are working on more effective antibiotics for skin infections. For instance, in May 2021, Teva Pharmaceutical Industries Ltd., had introduced the launch of its 250 mg and 500 mg strength generic Erythromycin tablets in order to treat a variety of bacterial infections, along with preventing initial or recurrent attacks of rheumatic fever in patients allergic to penicillin.
Get Sample Copy of this Report at
https://www.omrglobal.com/request-sample/impetigo-drug-market
Impact of COVID-19 Pandemic on Global Impetigo Drug Market
The COVID-19 pandemic had impacted the global impetigo drug market significantly owning to the lockdown in most nations to control the spread of the virus. It affected the overall demand for impetigo drugs in the market. Additionally, due to the COVID-19 pandemic, the supply chain had also been disrupted as a result of precautionary actions implemented by governments in various countries which in turn, adversely impacted the growth of the market.
Full Report is Available at
https://www.omrglobal.com/report-customization/impetigo-drug-market
Segmental Outlook
The global impetigo drug market is segmented based on drug class and distribution channel. Based on the drug class, the market is sub-segmented into fusidane, quinolones, sulfonamide, and tetracycline. Based on the distribution channel, the market is sub-segmented into online and offline.
By Drug Class (Fusidane, Quinolones, Sulfonamides, and Tetracycline),
By Distribution Channel (Online and Offline)
Market Players Outlook
The major companies serving the global impetigo drug market include Cutanea Life Sciences, GlaxoSmithKline plc., LEO Pharma A/S, Medimetriks Pharmaceuticals Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2022. copyright got approval for CIBINQO (abrocitinib) which is an oral inhibitor for the treatment of patients suffering from moderate to severe dermatitis. CIBINQO will be a significant new oral option for those who have not yet found relief. CIBINQO showed good efficacy in clearing skin, reducing itching, and managing the intensity and extent of eczema, with a benefit-risk profile that supports its usage in the FDA-approved patient population.
The Report Covers
Market value data analysis of 2021 and forecast to 2028.
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the global impetigo drug market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market-entry and market expansion strategies.
Competitive strategies by identifying ‘who-stands-where’ in the market.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404